ENI-SPIRE-2: A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications (clinicaltrials.gov) - Oct 23, 2026 - P3 | N=948 | Not yet recruiting | Sponsor: Hoffmann-La Roche
New P3 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
|